Pediatric placebo-controlled trials
Executive Summary
Pediatric subcommittee of the Anti-Infective Drugs Advisory Committee will meet Sept. 11 to discuss ethical considerations in the conduct of placebo-controlled clinical trials in the pediatric population. The subcommittee will also consider the development of psychotropic drugs for use in young children (1"The Pink Sheet" March 27, p. 26). The meeting will begin at 8 a.m. at the Hyatt Regency in Bethesda, Md